Pentair names Lance Bonner as executive VP, general counsel

Published 17/07/2025, 11:56
Pentair names Lance Bonner as executive VP, general counsel

LONDON - Pentair plc (NYSE:PNR), a company currently valued at $17.25 billion and rated with "GOOD" financial health by InvestingPro, announced Thursday the appointment of Lance Bonner as Executive Vice President, General Counsel and Secretary, effective August 11, 2025. Bonner will report directly to John Stauch, Pentair’s President and CEO.

Bonner is returning to Pentair where he previously served as Associate General Counsel for M&A and Securities. Most recently, he held the position of Associate General Counsel, Corporate and Assistant Secretary at Inspire Medical Systems, Inc., a publicly-traded medical device company.

"I am extremely pleased to welcome Lance back to Pentair as a member of our executive leadership team," said Stauch in a press release statement. "During his previous time at Pentair, Lance established himself as a trusted and customer-focused business partner."

Bonner began his legal career in private practice at Lindquist & Vennum (now Ballard Spahr) and Faegre Drinker Biddle & Reath. He graduated from the University of Pittsburgh and received his J.D. from the Washington University in St. Louis School of Law.

Pentair, which describes itself as a provider of sustainable water solutions, reported revenue of approximately $4.1 billion in 2024. The company employs around 9,750 people globally and serves customers in more than 150 countries.

In other recent news, Pentair has reported several significant developments that may interest investors. The company declared a quarterly cash dividend of $0.25 per share, marking the 49th consecutive year of dividend increases, a testament to its financial stability and commitment to shareholder returns. In the previous fiscal year, Pentair achieved revenues of approximately $4.1 billion. RBC Capital Markets raised Pentair’s stock price target to $101, maintaining an Outperform rating, following a first-quarter performance that exceeded expectations with an 8% operating beat. UBS adjusted its price target for Pentair to $110 from $115, while still maintaining a Buy rating, indicating continued confidence in the company’s strategic initiatives despite recent market volatility. JPMorgan also upgraded Pentair’s stock rating from Neutral to Overweight, increasing the price target to $113, reflecting a positive outlook on the company’s financial prospects. The firm anticipates that Pentair’s volume forecasts for the second half of the year are too conservative, suggesting potential upside. These developments highlight Pentair’s ongoing efforts to navigate economic challenges while maintaining a strong market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.